Back
Corporate News
Biofil Chemicals to convene board meeting November 14 to review financial results
03-Nov-2026, 02:43
Biofil Chemicals and Pharmaceuticals Limited will hold a meeting of its Board of Directors on November 14, 2026, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2026, along with the limited review report thereon. The company's BSE scrip code is 524396 and NSE symbol is BIOFILCHEM, with ISIN INE829A01014. Trading window for company securities will open 48 hours after the declaration of the financial results for designated persons, immediate relatives, and connected persons, as per SEBI regulations.